These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2470597

  • 21. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).
    Paris JM, Cunningham KA.
    Brain Res Bull; 1992 Jan; 28(1):115-9. PubMed ID: 1347247
    [Abstract] [Full Text] [Related]

  • 22. Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors.
    Schmidt CJ, Taylor VL.
    Eur J Pharmacol; 1990 May 31; 181(1-2):133-6. PubMed ID: 1974853
    [Abstract] [Full Text] [Related]

  • 23. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    Lowy MT, Nash JF, Meltzer HY.
    Eur J Pharmacol; 1989 Apr 12; 163(1):157-61. PubMed ID: 2472965
    [Abstract] [Full Text] [Related]

  • 24. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ, Abbate GM, Black CK, Taylor VL.
    J Pharmacol Exp Ther; 1990 Nov 12; 255(2):478-83. PubMed ID: 1978728
    [Abstract] [Full Text] [Related]

  • 25. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy").
    Colado MI, Granados R, O'Shea E, Esteban B, Green AR.
    Pharmacol Toxicol; 1999 Jun 12; 84(6):261-6. PubMed ID: 10401727
    [Abstract] [Full Text] [Related]

  • 26. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
    Schmidt CJ, Wu L, Lovenberg W.
    Eur J Pharmacol; 1986 May 13; 124(1-2):175-8. PubMed ID: 2424776
    [Abstract] [Full Text] [Related]

  • 27. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.
    Stone DM, Merchant KM, Hanson GR, Gibb JW.
    Neuropharmacology; 1987 Dec 13; 26(12):1677-83. PubMed ID: 2893986
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine.
    Elayan I, Gibb JW, Hanson GR, Foltz RL, Lim HK, Johnson M.
    Eur J Pharmacol; 1992 Oct 20; 221(2-3):281-8. PubMed ID: 1358654
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD, Katz JL, Ricaurte GA.
    Brain Res; 1992 Sep 04; 589(2):349-52. PubMed ID: 1382813
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Mar 04; 244(3):977-82. PubMed ID: 2472482
    [Abstract] [Full Text] [Related]

  • 35. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates.
    Ricaurte GA, DeLanney LE, Wiener SG, Irwin I, Langston JW.
    Brain Res; 1988 Dec 06; 474(2):359-63. PubMed ID: 2463059
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog.
    Johnson M, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1989 Jun 20; 165(2-3):315-8. PubMed ID: 2570704
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.